Karakteristik Dan Faktor Prediktor Komplikasi Abortus Di Rumah Sakit DR. Soeroto Ngawi

Dyan Amelia Permatasari, Titik Kuntari

Sari


Abortus merupakan salah satu penyebab kematian ibu di dunia, termasuk Indonesia. Ngawi merupakan salah satu kabupaten dengan angka kematian ibu yang melebihi rata-rata provinsi Jawa Timur. Penelitian bertujuan untuk menjelaskan karakteristik, tipe aborsi, penatalaksanaan, dan faktor prediktor komplikasi abortus di RS dr Soeroto, Kabupaten Ngawi pada periode 2018-2019. Penelitian cross-sectional menggunakan data sekunder pasien rawat inap di RS dr. Soeroto, Ngawi. Variabel meliputi karakteristik sosiodemografi, penatalaksanaan, serta faktor prediktif komplikasinya. Hasil menunjukkan bahwa pada periode tersebut, terdapat 120 kasus abortus, yang terdiri atas abortus imminens (48,3%), inkomplet (44,2%), komplet (4,2%), dan missed abortion (3,3%). Abortus paling banyak dialami oleh pasien dalam rentang usia 35-39 tahun (26,7%), berpendidikan SMA (37,5%) dan berprofesi sebagai ibu rumah tangga (40,8%). Mayoritas pasien mengalami komplikasi (53,3%). Komplikasi terbanyak adalah perdarahan (22,5%), infeksi (10%) dan syok hipovolemik (10%). Penatalaksanaan meliputi medikamentosa dan non medikamentosa. Terapi medikamentosa meliputi pemberian antibiotika, analgetika, hormon, sulfas ferosus, dan pemberian cairan infus. Preparat antibiotika merupakan terapi medikamentosa yang paling banyak digunakan (52,2%). Sebanyak 53 orang (44,2%) mendapatkan terapi nonmedikamentosa kuretase. Pendidikan ibu merupakan faktor yang paling berhubungan dengan risiko terjadinya komplikasi (aOR 3,4; IK95% 1,13-10,14, p-value 0,03). Penatalaksanaan medikamentosa dan non medikamentosa, berupa tindakan kuretase, diberikan sesuai dengan kondisi pasien. Pendidikan rendah merupakan faktor prediktif terjadinya komplikasi pada ibu yang mengalami abortus.


Kata Kunci


Abortus; Edukasi; Faktor prediktif; Komplikasi; Penatalaksanaan

Teks Lengkap:

PDF

Referensi


Amalia, S. R., Lestari, P., & Ningrum, A. G. (2022. Causative factor of delay in maternal referral- systematic review. Indonesia Midwifery and Health Sciences Journal 6 (1): 1-14 https://doi.org/10.20473/imhsj.v6i1.2022.1-14

Bello, F. A., Fawole, B., Oluborode, B., Awowole, I., Irinyenikan, T., Awonuga, D., Loto, O., Fabamwo, A., Guest, P., & Ganatra, B. (2018). Trends in misoprostol use and abortion complications: A cross-sectional study from nine referral hospitals in Nigeria. PLoS ONE, 13(12), 1e0209415. https://doi.org/10.1371/journal. pone.0209415

Blee, K., & Horner, P. J. (2021). New NICE abortion care guidance : what does it mean for antibiotic use ? BMJ Sex Reprod Health, 47, 69. https://doi.org/10.1136/bmjsrh-2020-200627

Chu, J. J., Devall, A. J., Beeson, L. E., Hardy, P., Cheed, V., Sun, Y., Roberts, T. E., Ogwulu, C. O., Williams, E., Jones, L. L., La, J. H., Papadopoulos, F., Bender-atik, R., Brewin, J., Hinshaw, K., Choudhary, M., Ahmed, A., Bottomley, C., Ross, J., … Coomarasamy, A. (2020). Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised , double-blind , placebo-controlled trial. The Lancet, 396(10253), 770–778. https://doi.org/10.1016/S0140-6736(20)31788-8

Devall, A. J., Papadopoulou, A., Podesek, M., Haas, D. M., Price, M. J., Coomarasamy, A., & Gallos, I. D. (2021). Progestogens for preventing miscarriage: a network meta-analysis (Review). Cochrane Database Syst Rev, 4(4), CD013792. https://doi.org/10.1002/14651858.CD013792.pub2

Dinas Kesehatan Provinsi Jawa Timur. (2022). Profil Kesehatan Provinsi Jawa Timur 2021. Dinas Kesehatan Provinsi Jawa Timur. https://dinkes.jatimprov.go.id/userfile/dokumen/PROFIL%20KESEHATAN%202021%20JATIM.pdf

Dugas, C., & Slane, V. H. (2022). Miscarriage. In StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK532992/

Gupta, A. (2013). A comparative study of methylergonovine and 15-methyl prostaglandin F 2 α in active management of third stage of labor. Obstet Gynecol Sci, 56(5), 301–306. https://doi.org/10.5468/ogs.2013.56.5.301

Hasjmy, I. R. M., Ferry, F., & Bachtiar, H. (2022). The relationship delay in referral with maternal mortality Dr. M. Djamil central general hospital Padang. Andalas Obstetrics and Gynecology Journal 6(1). https://jurnalobgin.fk.unand.ac.id/index.php/JOE/article/view/253/20

Jones, A. J., Federspiel, J. J., & Eke, A. C. (2023). Preventing postpartum hemorrhage with combined therapy rather than oxytocin alone pharmacologic therapy. Am J Obstet Gynecol MFM, 5(2 Suppl), 100731. https://doi.org/10.1016/j.ajogmf.2022.100731

Jones, G. L., Mitchell, C. A., Hirst, J. E., & Anumba, D. O. C. (2022). Understanding the relationship between social determinants of health and maternal mortality. BJOG: Int J Obstet Gy, February, 1211–1228. https://doi.org/10.1111/1471-0528.17044

Karlsen, S., Say, L., Souza, J., Hogue, C. J., Calles, D. L., Gülmezoglu, A. M., & Raine, R. (2011). The relationship between maternal education and mortality among women giving birth in health care institutions : Analysis of the cross sectional WHO Global Survey on

Maternal and Perinatal Health. BMC Public Health, 11, 606.

Lissauer, D., Wilson, A., Hewitt, C., Middleton, L., Bishop, J. R. B., Daniels, J., Merriel, A., Weeks, A., Mhango, C., Mataya, R., Taulo, F., Ngalawesa, T., Chirwa, A., Mphasa, C., Tambala, T., Chiudzu, G., Mwalwanda, C., Mboma, A., Qureshi, R., … Ahmet M Gulmezoglu 1, Arri Coomarasamy A Bhutta 1, Ahmet M Gulmezoglu 1, A. C. (2019). A Randomized Trial of Prophylactic Antibiotics for Miscarriage Surgery. N Engl J Med, 380(11), 1012–1021. https://doi.org/10.1056/NEJMoa1808817

Muramoto, O. T., Calfee, A. L., Shorter, J. M., Creinin, M. D., & Hou, M. Y. (2017). Quality Improvement : Changing Patterns of Antibiotic Prophylaxis for Surgical Abortion. J Healthc Qual, 39(5), e79–e83. https://doi.org/10.1097/jhq.0000000000000074

Şentürk, Ş., Kağıtçı, M., Balık, G., Arslan, H., & Şahin, F. K. (2016). The Effect of the Combined Use of Methylergonovine and Oxytocin during Caesarean Section in the Prevention of. Basic Clin Pharmacol Toxicol, 118, 338–343. https://doi.org/10.1111/bcpt.12500

Wall, L. L., & Yemane, A. (2022). Infectious Complications of Abortion. Open Forum Infect Dis, 9(11), ofac553. https://doi.org/10.1093/ofid/ofac553

Wirawan, F., Gede, D., Yudhantari, A., & Gayatri, A. (2023). Pre-pregnancy Diet to Maternal and Child Health Outcome: A Scoping Review of Current Evidence. J Prev Med Public Health, 56, 111–127. https://doi.org/10.3961/jpmph.22.472

World Health Organization. (2016). Guideline: Iron Supplementation in Postpartum Women. WHO Press.

World Health Organization. (2023). Why we need to talk about losing a baby. https://www.who.int/news-room/spotlight/why-we-need-to-talk-about-losing-a-baby

Wu, H., Marwah, S., Wang, P., Wang, Q., & Chen, X. (2017). Misoprostol for medical treatment of missed abortion : a systematic review and network meta-analysis. Sci Rep, 7(1), 1664. https://doi.org/10.1038/s41598-017-01892-0

Xu, Q., Chen, J., Wei, Z., Brandon, T., Zava, D., Shi, Y. E., & Cao, Y. (2017). Sex Hormone Metabolism and Threatened Abortion. Med Sci Monit, 23, 5041–5048. https://doi.org/10.12659/MSM.904500

Zhao, X., Zhang, C., Lou, H., & Wu, C. (2021). Clinical Efficacy and Safety Study of Mifepristone with Misoprostol Treatment in Patients with Missed Abortion. Evid Based Complement Alternat Med, 2021, 9983023. https://doi.org/10.1155/2021/9983023

Zhou, J., Huang, Z., Pan, X., Leung, W. T., Li, C., Chen, L., Zhang, Y., Wang, L., Sima, Y., Zhang, N., Qiu, X., Li, L., & Wang, L. (2019). New thoughts in exploring the pathogenesis, diagnosis, and treatment of threatened abortion. BioScience Trends, 13(3), 284–285.

https://doi.org/10.5582/bst.2019.01155




DOI: https://doi.org/10.33024/jikk.v12i10.19977

Refbacks

  • Saat ini tidak ada refbacks.


##submission.copyrightStatement##

##submission.license.cc.by-nc4.footer##

Pendidikan Dokter Universitas Malahayati Lampung



Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.